And our study also confirmed that the five candidate genes including BGN, LGALS1, MMP1, SERPINB5, and TM4SF4 from tumor budding and the microenvironment signified a poorer prognosis for CRC patients when they were highly expressed. This evidence concerns the gene LGALS1 and neoplasm.